Avanos Medical's basic earnings per share (Basic EPS) for the
three
months ended in Dec. 2024 was $-8.64.
Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2024 was $-8.52.
Avanos Medical's EPS (Diluted) for the
three
months ended in Dec. 2024 was $-8.64.
Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $-8.53.
Avanos Medical's EPS without NRI for the
three
months ended in Dec. 2024 was $0.43.
Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2024 was 1.30.
During the past 13 years, Avanos Medical's highest 3-Year average EPS without NRI Growth Rate was 56.40% per year. The lowest was -52.60% per year. And the median was 6.20% per year.
Avanos Medical EPS (Basic) Historical Data
The historical data trend for Avanos Medical's EPS (Basic) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.
Avanos Medical's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as
EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-8.52
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Avanos Medical (NYSE:AVNS) EPS (Basic) Explanation
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Avanos Medical EPS (Basic) Related Terms
Thank you for viewing the detailed overview of Avanos Medical's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AVNS has been successfully added to your 